ALFA Finder| Value | ₹6.17 Cr |
|---|
BSE filing, NSE: SHUKRAPHAR. Summary written from the filing by ALFA Finder's alert engine.
Shukra Pharmaceuticals Ltd: key numbers
- Share price
- ₹79.97
- Market cap
- ₹3,539 Cr
- Revenue (annual)
- ₹56.73 Cr
- Net profit (annual)
- ₹22.06 Cr
- P/E (TTM)
- 79.8×Sector 43.0×
- Promoter holding
- 51.15%+0.19% QoQ
- FII holding
- 0.43%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shukra Pharmaceuticals Ltd
All →Shukra Pharmaceuticals Other Announcement
Shukra Medtech confirmed no deviation in the use of funds from its preferential convertible warrant issue. The company received ₹10.46 Crore, 75% of the consideration, from allottees.
- Value
- ₹10.46 Cr
Shukra Pharmaceuticals Q2 FY27 Results: Net Profit ₹12.7 Cr, Up 429.2% YoY
Shukra Pharmaceuticals Ltd reported revenue from operations of ₹44.2 Cr (+649.2% YoY) and net profit of ₹12.7 Cr (+429.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹12.7 Cr · +429.2% YoY
Shukra Pharmaceuticals Board Meeting Date
Shukra Medtech Limited has scheduled a board meeting on November 3, 2026, to consider and approve its unaudited financial results for the quarter ended September 2026.
Shukra Pharmaceuticals Other Announcement
Shukra Medtech submitted a revised CA certificate to NSE for its name and symbol change application. The filing requests final exchange approval for the corporate rename.
Shukra Pharmaceuticals Other Announcement
Shukra Pharmaceuticals Limited has submitted the certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Shukra Pharmaceuticals Capital Structure Change
Shukra Pharmaceuticals allotted 17.35 lakh equity shares upon warrant conversion to promoters. The exercise raised Rs. 4.63 Crore, increasing the paid-up capital.
- Value
- ₹4.63 Cr
Other preferential issue announcements
All →AUDROC Preferential Issue
Audroc Limited submitted a statutory auditor certificate under Regulation 169(5) of the ICDR Regulations. It confirms preferential issue consideration was received from allottees' bank accounts.
Batliboi Preferential Issue
Batliboi Ltd shared the voting results of its EGM held on 6 November 2026, covering resolutions on converting promoter Nirmal Bhogilal's preference shares and unsecured loan into equity. The filing also includes the scrutinizer's report, and all three shown resolutions passed.
Sharvaya Metals Preferential Issue
Sharvaya Metals shareholders approved a preferential issue of equity shares and convertible warrants on November 6, 2026. All resolutions passed with 100% of votes cast in favour.
Harmony Capital Services Preferential Issue
Harmony Capital received BSE in-principle approval for a share-swap preferential issue of up to 1.26 crore shares. Issue value is ₹83.47 Crore at the ₹66 floor price.
- Value
- ₹83.47 Cr
ACE Software Exports Preferential Issue
Ace Software Exports Limited has issued a postal ballot notice seeking shareholder approval for two special resolutions. The resolutions cover preferential issues of equity shares to MyUtilityGenius Limited and MyUtilityGenius Commercial Limited for consideration other than cash.
Ace Software Exports Ltd Partly Paidup Preferential Issue
Ace Software Exports sought approval via postal ballot for two preferential share issues to MyUtilityGenius entities. The combined issue consideration is about ₹10.76 Crore.
- Value
- ₹10.76 Cr